Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Historical Acquisition Tree
clobetasol (dermovate) (1985 NDA)
ranitidine (zantac) (1984 NDA)
salmeterol (serevent) (1994 NDA)
sumatriptan (zecuity) (NDA)
Key: Glaxo (0) Acquired (4)
darbepoetin alfa (aranesp) (2 trials)
epoetin (Epogen) (4 trials)
methoxy polyethylene glycol-epoetin beta (Mircera) (1 trial)
peginesatide (Omontys) (17 trials)
Asthma
Asthma, Exercise-Induced
Bronchitis, Chronic
Cluster Headache
Cystic Fibrosis
Dermatitis
Duodenal Ulcer
Emphysema
Gastroesophageal Reflux
Migraine Disorders
Migraine with Aura
Migraine without Aura
Peptic Ulcer
Psoriasis
Pulmonary Disease, Chronic Obstructive
Zollinger-Ellison Syndrome
Trials (17 total)
Trial APIs (4 total)